CellPort

CellPort boasts the most innovative suite of cloud-based cell-manufacturing and lab execution platforms in the life-sciences industry.

[CellPort @CellPortSW]

Inventory says the material exists. But it can't be found.
Mislabeled vial. Wrong lot. Wrong passage. Wrong clone. Record and reality don't match.
It shows up across every program, every stage.
CellPort connects materials and execution — so records update as the process happens.

[CellPort @CellPortSW]

By the end of the week, your team is still trying to figure out why the run deviated.
Unexpected deviation. Weeks of investigation.
Most of that time wasn't spent solving — it was spent finding information that should have already been there.
That's why CellPort was built.

[CellPort @CellPortSW]

CellPort at Reproducibility in Science 2026, June 16–18. Reproducibility starts at bench but depends on coordinating cells, protocols, and time. When context lives in notebooks, spreadsheets, and memory, it suffers. CellPort makes quality traceable and reproducibility achievable.

[CellPort @CellPortSW]

The CMC challenges in cell-based products are predictable. So why do they keep appearing late — when they're already costly?

Because the infrastructure to catch them early hasn't existed in one place. Until now.

CellPort — The Operating System for Cell-Based Products.

[CellPort @CellPortSW]

Your results are decided before you reach them.

Operational control happens in stages, each one building on the last.

CellPort gives labs control at every layer — from materials and inventory to equipment, protocols, and insight.
https://t.co/85v49VKF5i

[CellPort @CellPortSW]

Operational bottlenecks rarely begin where teams expect them to.

Time-to-value improves when operational control is established layer by layer:
• Materials
• Inventory
• Equipment
• Protocols
• Insight

Early operational visibility helps teams improve consistency over time.

[CellPort @CellPortSW]

Cell lines are shaped by how they’re handled, maintained, and passaged over time.

The future lab is not just digital. It’s a lab with memory.

CellPort helps preserve process history and operational context as work happens.

See it in practice: https://t.co/aJ56aPsCog

[CellPort @CellPortSW]

Advancing cell and gene therapies depends on how work is carried forward over time.

CellPort will be attending the ASGCT in Boston, May 11–15.

How work is performed—not just results—shapes traceability and consistency.

https://t.co/ME93wbBepc

[CellPort @CellPortSW]

CMC isn’t the problem—when you start is.

Patrick Dentinger, our CEO, will be speaking May 8 at 11:30 AM during the CMC Track at the Philly Cell & Gene Therapy Conference.

How work is captured early matters later—especially when it needs to be repeated.
https://t.co/26PWIG2v2B

[CellPort @CellPortSW]

At ISCT 2026, focus centers on advancing cell and gene therapies across development, manufacturing, and regulatory. CellPort will be in Dublin, May 6–9. Understanding how work was performed over time continues to shape how these therapies move forward. https://t.co/XEw5CfSfZf

[CellPort @CellPortSW]

At PEGS 2026, focus continues to center on protein engineering and antibody development. CellPort will be in Boston on May 11–15. How experimental work is captured and carried forward across teams continues to shape how these programs evolve.
https://t.co/smsIW96yKA

[CellPort @CellPortSW]

Cell & gene therapy is advancing, and conversations around CMC are evolving.

At the 2026 Cell & Gene Therapy Annual Conference in Philadelphia, Patrick Dentinger will present “CMC Isn’t the Problem — When You Start Is” on May 8 from 10:30–12:00 (CMC Track, Session 1).

[CellPort @CellPortSW]

On April 17, we will be in São Paulo, Brazil for the International Regenerative Medicine Conference Brazil 2026.
As regenerative medicine is applied in practice, how processes are captured and repeated becomes just as important as the therapies themselves.
https://t.co/uS4w9qTsKo

[CellPort @CellPortSW]

Protocols are described as the blueprint for lab operations.

When executed, they capture materials, equipment, who performed the work, and when, along with measurements and parameters.

Over time, they become repositories of institutional knowledge.

[CellPort @CellPortSW]

Most workflows have the right pieces in place. The challenge is how they come together.

Time, people, protocols, materials, equipment—usually documented, but not always connected.

Without context, interpreting what happened becomes harder.

https://t.co/aYtwXMhWSY

[CellPort @CellPortSW]

As cells are passaged, changes begin to occur. Growth can slow, morphology can change, and key phenotypes can be lost. These changes aren’t always obvious but can impact endpoint integrity and reproducibility. Tracking passage number helps keep that clear.
https://t.co/tWBMY657jv

[CellPort @CellPortSW]

Same protocol. Different result.

In cell culture, that’s not unusual.
It’s not just the steps—it’s how the culture moves through them.

Passaging, growth, media, handling—all part of one workflow.

It’s easier to understand when it’s connected.
https://t.co/MZp7hcTRIr

[CellPort @CellPortSW]

Cells carry history.

From passage to passage, context builds—but lineage isn’t always captured clearly.
When experimental data is connected back to workflows, the picture becomes clearer.

Context is what gives it meaning.

[CellPort @CellPortSW]

Cells are central to the future of life science.

Yet many labs still manage cell culture and manufacturing records across notebooks, spreadsheets, and emails.

CellPort brings cell-based activities into one system—supporting traceability, visibility, and regulatory compliance.

[CellPort @CellPortSW]

Cell lineage provides critical context for understanding how cultures evolve over time. As cell-based research advances, documenting lineage is becoming increasingly important for maintaining scientific traceability.
https://t.co/NyNvQiSJEA